|Day Low/High||32.65 / 32.97|
|52 Wk Low/High||29.83 / 35.38|
Previously studies already showed improvement from use of Exelixis's Cabometyx over Pfizer's Sutent in treating kidney cancer patients.
The most recent short interest data has been released for the 07/31/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Here's what you need to know now for Wed., Aug. 9.
The blue-chip index gets all the attention, but doesn't necessarily deserve it.
Allergan's earnings weren't sterling, but with the fourth quarter conventionally standing as their strongest, here's what investors can look forward to.
Pfizer Inc. announced today that the United States Food and Drug Administration's (FDA) Arthritis Advisory Committee (AAC) voted 10 to 1 to recommend approval of the proposed dose of tofacitinib for the treatment of adult...
Analysts at BMO Capital expect 'positive updates' on the company's pipeline that could improve investors' view on the company.
Here's what you need to know now.
Pfizer post earnings beat.
Jim Cramer weighs in on Tuesday's trending stocks.
U.S. stock futures were pointing to strong gains for Wall Street on Tuesday
The Dow Jones Industrial Average is looking at a strong open and possibly could cross the 22,000 milestone today.
Soon enough, we'll know where the demand lies.
Oil major swings to profit as crude prices recover
The Dow is poised to open at an all-time high on Tuesday.
Pfizer Inc. (NYSE:PFE) reported financial results for second-quarter 2017, increased the midpoint of its 2017 financial guidance range for Adjusted diluted EPS (2) and reaffirmed its 2017 financial guidance range for...
A glimpse of what to expect during Tuesday's pre-market.
The labor market goes under inspection and Apple releases its earnings report.